SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-18-000046
Filing Date
2018-11-07
Accepted
2018-11-07 16:49:37
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a9301810qaxovant.htm 10-Q 1172018
2 EXHIBIT 10.1 a93018exhibit101.htm EX-10.1 611512
3 EXHIBIT 10.2 a93018exhibit102.htm EX-10.2 12577
4 EXHIBIT 31.1 a93018exhibit311.htm EX-31.1 10104
5 EXHIBIT 31.2 a93018exhibit312.htm EX-31.2 10028
6 EXHIBIT 32.1 a93018exhibit321.htm EX-32.1 6335
7 EXHIBIT 32.2 a93018exhibit322.htm EX-32.2 6195
  Complete submission text file 0001636050-18-000046.txt   4275208

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT axon-20180930.xml EX-101.INS 421037
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20180930.xsd EX-101.SCH 34668
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20180930_cal.xml EX-101.CAL 48253
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20180930_def.xml EX-101.DEF 141398
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20180930_lab.xml EX-101.LAB 417813
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20180930_pre.xml EX-101.PRE 238812
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 181167022
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1